Skip to the catalogue
halfrx
← All providers and medications

The cheapest GLP-1, ranked

17 of the 40 providers and medications on this site publish an all-in maintenance price that could be verified. They are ranked here by that figure — then segmented, because the cheapest option for someone paying cash is not the cheapest option for someone with a plan that covers it.

Last updated 2026-06-10the most recent price verification in this ranking

What is the cheapest GLP-1 you can actually get?

The cheapest verified all-in price on halfrx is Qsymia (phentermine/topiramate) at $98 a month at the maintenance dose, checked against its own published page on 2026-08-20. The dearest is Calibrate at $548, a spread of $450 a month for treatment in the same category — $5,400 across a year. The figure that matters is the maintenance price rather than the advertised one, because the starting dose is not the dose anyone stays on and an introductory rate covers a month or two of a course measured in years. 4 of the ranked options are compounded rather than FDA approved, which is a legal status and not a quality claim, and they sit at the cheap end for that reason. Of the 40 cards here, 23 publish no maintenance figure at all and carry no price rather than an estimate.

Cheapest if you are paying cash

The rule: Verified maintenance price, no insurance billed, and no FTC action, state action, BBB F grade or FDA warning letter on the card.

  1. 1Noom Med$249/moverified 2026-08-20compounded
  2. 2LillyDirect$299/moverified 2026-08-20
  3. 3Hone Health$315/moverified 2026-08-19
  4. 4NovoCare Pharmacy$349/moverified 2026-08-24

Cheapest medication, bought direct

The rule: Medications with a verified maintenance price, ranked. These are the drug itself rather than a programme wrapped around it.

  1. 1Qsymia$98/moverified 2026-08-20
  2. 2Contrave$99/moverified 2026-08-20Boxed warning
  3. 3Ozempic$199/moverified 2026-06-10
  4. 4Compounded semaglutide$199/moverified 2026-06-10compoundedNot FDA approvedSupply risk
  5. 5Compounded tirzepatide$200/moverified 2026-06-10compoundedNot FDA approvedManufacturer lawsuitSupply risk

Cheapest FDA-approved option

The rule: Excludes compounded copies, which are made under the pharmacy-compounding exemption and are not FDA-approved products.

  1. 1Qsymia$98/moverified 2026-08-20
  2. 2Contrave$99/moverified 2026-08-20Boxed warning
  3. 3Ozempic$199/moverified 2026-06-10
  4. 4LillyDirect$299/moverified 2026-08-20
  5. 5Foundayo$299/moverified 2026-08-20

Highest scored, whatever the price

The rule: The published formula in full: cost, transparency, terms, evidence and record. Arithmetic over stored fields, not an editor's ordering.

  1. 1LillyDirect8.3/10$149–$449/moverified 2026-08-20
  2. 2LifeMD8.3/10$368/moverified 2026-08-19
  3. 3Hone Health8.1/10$315–$415/moverified 2026-08-19
  4. 4Knownwell8.1/10$299–$399/moverified 2026-06-10
  5. 5GoodRx for Weight Loss8.0/10$388/moverified 2026-06-10

Everything with a verified price

Cheapest first. The score column is the published formula; where it disagrees with the price order, the reason is on the card.

#Provider or medicationAt maintenanceScoreVerified
1Qsymia$98/mo6.92026-08-20
2Contrave$99/mo6.62026-08-20
3Mochi Healthcompounded$178/mo4.52026-08-19
4Ozempic$199/mo7.52026-06-10
5Compounded semaglutidecompounded$199/mo2.92026-06-10
6Compounded tirzepatidecompounded$200/mo2.92026-06-10
7Noom Medcompounded$249/mo5.42026-08-20
8LillyDirect$299/mo8.32026-08-20
9Foundayo$299/mo7.52026-08-20
10Hone Health$315/mo8.12026-08-19
11Wegovy$349/mo7.42026-08-19
12NovoCare Pharmacy$349/mo7.82026-08-24
13LifeMD$368/mo8.32026-08-19
14Saxenda$415/mo5.42026-06-10
15Zepbound$449/mo7.82026-08-19
16Mounjaro$499/mo6.12026-08-24
17Calibrate$548/mo6.82026-08-19

23 that cannot be ranked

These publish no all-in maintenance price that could be verified against their own pages. That is a fact about the seller rather than a gap in this table, and it is why they carry no figure here instead of an estimate.

How this ranking works

What does cheapest mean here?
The lowest all-in price a month at the maintenance dose — the dose you stay on, not the starting dose an introductory rate covers. Where a seller publishes a membership fee and a medication price separately, halfrx adds them; where a seller publishes no maintenance figure at all, it appears with no price rather than with a guess, and cannot be ranked.
Why is a cheaper option not always ranked higher?
Because price is one component of a published formula, not the whole of it. An open FTC action, a state action or a failing BBB grade caps a card at 4.5 out of 10 whatever its price, and a card with no verified price scores zero on cost. The ranking by price and the ranking by score are shown separately here so you can see where they disagree.
Is anything on this list paid placement?
No. No provider can buy a position, a score, or a flag removed. Some outbound links earn a commission and every one of them says so beside itself; commission status is not an input to any component of the score, and a company under an open FTC action gets no commission link at all.

Bands used for the cost component of the score run $151$548 for providers and $98$499 for medications, recomputed from the live data rather than fixed, so a new cheapest option moves the scale rather than sitting off the end of it. Recompute any score yourself: the formula is published in full and the inputs are in catalogue.json.